Capastat and hyperkalaemia Patient Reports February 13, 2012

Capastat Side Effects Report #5802581-X
Capastat side effect was reported by a Consumer or non-health professional from SOUTH AFRICA on June 24, 2008. Female patient, weighting 83.78 lb, was diagnosed with tuberculosis  and was treated with Capastat. After drug was administered, patient experienced the following side effects: diarrhoea, hyperkalaemia, renal failure acute. Capastat dosage: 500 MG, DAILY (1/D). During the same period patient was treated with TERIZIDONE, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, ETHIONAMIDE, COTRIMOXAZOLE, VITAMINS. Patient was hospitalized. Patient died on 01/25/2008.